Xiang Ma

639 total citations
26 papers, 435 citations indexed

About

Xiang Ma is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiang Ma has authored 26 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiang Ma's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Xiang Ma is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Xiang Ma collaborates with scholars based in China. Xiang Ma's co-authors include Likun Zhuang, Zusen Wang, Chao Yang, Liqun Wu, Bing Han, Yunjin Zang, Xin Wang, Zehua Wu, Zheng Lü and Hao Zou and has published in prestigious journals such as The FASEB Journal, Journal of Cellular Biochemistry and Cell Death and Disease.

In The Last Decade

Xiang Ma

23 papers receiving 433 citations

Peers

Xiang Ma
Xiang Ma
Citations per year, relative to Xiang Ma Xiang Ma (= 1×) peers Mei-Fang Zhang

Countries citing papers authored by Xiang Ma

Since Specialization
Citations

This map shows the geographic impact of Xiang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Ma more than expected).

Fields of papers citing papers by Xiang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Ma. The network helps show where Xiang Ma may publish in the future.

Co-authorship network of co-authors of Xiang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Ma. A scholar is included among the top collaborators of Xiang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Ma. Xiang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Xiang, Kun Jiang, Weiquan Wang, et al.. (2025). Rotenone inhibited osteosarcoma metastasis by modulating ZO-2 expression and location via the ROS/Ca 2+ /AMPK pathway. Redox Report. 30(1). 2493556–2493556.
2.
Ma, Xiang, et al.. (2024). Functional investigation and two-sample Mendelian randomization study of primary biliary cholangitis hub genes. World Journal of Clinical Cases. 12(30). 6391–6406.
3.
Xiao, Jian, et al.. (2023). Prognostic Value of Tumor Size in Gastric Cancer: A Retrospective Cohort Study Based on SEER Database. International Journal of Surgical Pathology. 31(7). 1273–1282. 3 indexed citations
4.
Dong, Suwei, et al.. (2023). Metformin sensitises osteosarcoma to chemotherapy <em>via</em> the IGF-1R/miR-610/FEN1 pathway. European Journal of Histochemistry. 67(2). 3 indexed citations
5.
Xie, Bo, Xiang Ma, Lan Zhang, et al.. (2023). Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma. Frontiers in Oncology. 13. 1144269–1144269. 10 indexed citations
7.
Zhang, Chunxiao, Xiang Ma, Qian Yang, et al.. (2019). <p>Upregulation of STC2 in colorectal cancer and its clinicopathological significance</p>. OncoTargets and Therapy. Volume 12. 1249–1258. 33 indexed citations
8.
Dong, Suwei, et al.. (2019). <p>miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy</p>. OncoTargets and Therapy. Volume 12. 10089–10098. 24 indexed citations
9.
Ma, Xiang, Ming Lü, Wenjuan Tang, et al.. (2019). microRNA‐501‐5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1. Journal of Cellular Biochemistry. 121(2). 1911–1922. 27 indexed citations
10.
Shen, Jian, et al.. (2019). Digestive tract reconstruction options after laparoscopic gastrectomy for gastric cancer. World Journal of Gastrointestinal Oncology. 12(1). 21–36. 13 indexed citations
11.
Shen, Jian, Xiaogang Dong, Zhu Liu, et al.. (2018). Modularized laparoscopic regional en bloc mesogastrium excision (rEME) based on membrane anatomy for distal gastric cancer. Surgical Endoscopy. 32(11). 4698–4705. 12 indexed citations
12.
Liu, Liyang, Ming Lü, Xiang Ma, et al.. (2018). Association of MUC1 rs4072037 Functional Polymorphism and Cancer Risk: Evidence from 12551 Cases and 13436 Controls. Journal of Cancer. 9(18). 3343–3351. 3 indexed citations
13.
Gu, Xi, Liyang Liu, Ming Lü, et al.. (2018). Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysis. Journal of Cancer. 9(18). 3334–3342. 8 indexed citations
14.
Liu, Zhong, et al.. (2018). Neuroendocrine tumor of the common bile duct: a case report and review of the literature. OncoTargets and Therapy. Volume 11. 2295–2301. 9 indexed citations
15.
Zhuang, Likun, Xin Wang, Zusen Wang, et al.. (2017). MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma. Cell Death and Disease. 8(5). e2804–e2804. 36 indexed citations
16.
Dong, Sheng, Xiang Ma, Zusen Wang, et al.. (2017). YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor. Oncotarget. 8(25). 40583–40593. 19 indexed citations
17.
Zhang, Ming, Wenlin Chen, Yiyin Tang, et al.. (2017). Opposite response to hypoxia by breast cancer cells between cell proliferation and cell migration: A clue from microRNA expression profile. Oncology Letters. 15(3). 2771–2780. 14 indexed citations
18.
Ma, Xiang, Xin Wang, Chao Yang, et al.. (2016). DANCR Acts as a Diagnostic Biomarker and Promotes Tumor Growth and Metastasis in Hepatocellular Carcinoma. Anticancer Research. 36(12). 6389–6398. 77 indexed citations
19.
Zhang, Jing, Jian Dong, Zuozhang Yang, et al.. (2015). Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance. World Journal of Surgical Oncology. 13(1). 168–168. 15 indexed citations
20.
Zhang, Dengyong, et al.. (2015). Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.. PubMed. 8(3). 3386–94. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026